Advertisement
top banner image  

topleft corner image     top right corner image
 
ACCF/AHA Clinical Guidelines and Statements

CME logo image
bullet
bullet
bullet
bullet

JACC Homepage JACC Imaging Homepage
Still not a subscriber to JACC Imaging or JACC Interventions?

take action
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet

acc links
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet

jacc interventions image
bullet
bullet
bullet
bullet

     top nav image

     

J Am Coll Cardiol Intv, 2008; 1:279-285, doi:10.1016/j.jcin.2008.01.009
© 2008 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, J.
Right arrow Articles by Chronos, N.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Li, J.
Right arrow Articles by Chronos, N.

Clinical Research

Abnormal Vasomotor Function of Porcine Coronary Arteries Distal to Sirolimus-Eluting Stents

Jinsheng Li, MD, PhD, Refat Jabara, MD*, Lakshmana Pendyala, MD, Yoritaka Otsuka, MD, Toshiro Shinke, MD, Dongming Hou, MD, PhD, FACC, Keith Robinson, PhD, FACC, Nicolas Chronos, MD, FACC

Saint Joseph's Translational Research Institute/Saint Joseph's Hospital of Atlanta, Georgia.

* Reprint requests and correspondence: Dr. Refat Jabara, Saint Joseph's Translational Research Institute/Saint Joseph's Hospital of Atlanta, 5673 Peachtree Dunwoody Road, Suite 675, Atlanta, Georgia 30342. (Email: rjabara{at}sjha.org).

Objectives: This study sought to determine vasomotor functional responses of conduit coronary artery distal to bare-metal stents (BMS), polymer-only stents (POLY), and sirolimus-eluting stents (SES) in a clinically relevant animal model.

Background: Drug-eluting stents (DES) reduce in-stent restenosis, and also affect neointima formation and vascular remodeling in downstream coronary segments. Whether distal artery vasomotor function is also influenced by DES has not been determined.

Methods: Pigs (n = 12) received coronary stent implants, and hearts were harvested at 1 month. Arterial segments ≥15 mm distal to stents were excised and studied in an organ-chamber apparatus. Endothelium-dependent and endothelium-independent relaxation and contraction to classical agonists were measured.

Results: The SES showed increased lumen area and reduced neointima; abnormal vasomotor function of conduit arteries distal to SES also was observed. Contraction to endothelin-1 was significantly enhanced for SES compared with both BMS and POLY. Endothelium-dependent relaxation to a maximal dose of substance P was attenuated for SES compared with both BMS and POLY (46 ± 6% vs. 71 ± 3% and 78 ± 3%, respectively, p < 0.001). Endothelium-independent relaxation to sodium nitroprusside was potentiated for SES, compared with BMS and POLY (100 ± 5% vs. 69 ± 7% and 77 ± 5%, respectively, p = 0.02).

Conclusions: Stent-based local delivery of sirolimus profoundly inhibited neointima formation but caused vasomotor dysfunction in distal conduit vessel segments. These observations suggest that distal coronary vasospasm may be more readily evoked in the presence of DES and contribute to pathophysiological sequela.

Abbreviations and Acronyms
  BMS = bare-metal stent(s)
  DES = drug-eluting stent(s)
  ET = endothelin
  eNOS = endothelial nitric oxide synthase
  IEL = internal elastic lamina
  L-NAME = NW-nitro-L-arginine methyl ester
  LST = late stent thrombosis
  PGF2{alpha} = prostaglandin F2{alpha}
  POLY = polymer-only coated stent(s)
  SES = sirolimus-eluting stent(s)
  SNP = sodium nitroprusside




This article has been cited by other articles:


Home page
J Am Coll Cardiol IntvHome page
H. M.M. van Beusekom and P. W. Serruys
Drug-Eluting Stent Endothelium: Presence or Dysfunction
J. Am. Coll. Cardiol. Intv., January 1, 2010; 3(1): 76 - 77.
[Full Text] [PDF]


Home page
J Am Coll Cardiol IntvHome page
L. K. Pendyala, X. Yin, J. Li, J. P. Chen, N. Chronos, and D. Hou
The First-Generation Drug-Eluting Stents and Coronary Endothelial Dysfunction
J. Am. Coll. Cardiol. Intv., December 1, 2009; 2(12): 1169 - 1177.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll Cardiol IntvHome page
L. K. Pendyala, J. Li, T. Shinke, S. Geva, X. Yin, J. P. Chen, S. B. King III, K. A. Robinson, N. A.F. Chronos, and D. Hou
Endothelium-Dependent Vasomotor Dysfunction in Pig Coronary Arteries With Paclitaxel-Eluting Stents Is Associated With Inflammation and Oxidative Stress
J. Am. Coll. Cardiol. Intv., March 1, 2009; 2(3): 253 - 262.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll Cardiol IntvHome page
H. Kaneda, A. Yeung, and F. Ikeno
Tissue Sirolimus Levels of Distal Vessel, Stented Myocardium, and Distal Myocardium
J. Am. Coll. Cardiol. Intv., October 1, 2008; 1(5): 595 - 595.
[Full Text] [PDF]


Home page
J Am Coll Cardiol IntvHome page
R. Jabara, J. Li, and K. Robinson
Reply
J. Am. Coll. Cardiol. Intv., October 1, 2008; 1(5): 595 - 595.
[Full Text] [PDF]



Advertisement
 
   
 
home link current link search link archive link topics link cardiology careers link